Featured Content
We spoke with Susan E. Schindler, MD, PhD, lead author of a study about the effect of race on the prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light.
Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.
Richard K. Bogan, MD, discusses the importance of lowering sodium intake and improving heart health for patients with narcolepsy.
Edmund Tsui, MD, social media editor for the American Academy of Ophthalmology’s journal Ophthalmology, guides readers through what’s trend-worthy in eye care.
In this ninth update to the living guideline on COVID-19 therapeutics, the World Health Organization evaluates the use of nirmatrelvir/ritonavir for nonsevere COVID-19 and revises prior recommendations regarding the use of remdesivir.
Glaucoma experts Mildred Olivier, MD, and Ying Han, MD, provide guidance for improving in-office instructions.
Andrea Leonardi, MD, Dagny Zhu, MD, and Leonard Bielory, MD, describe this relatively rare ophthalmological condition that can threaten vision if left untreated.
These 5 takeaways from the meeting offer findings relevant to general ophthalmologists as well as pediatric specialists. Michael Repka, MD, and Lauren Ditta, MD explain the nuances of their research.